Lv2
110 积分 2023-07-06 加入
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
1天前
已完结
The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma
25天前
已完结
Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications
25天前
已关闭
Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain–containing factors
26天前
已完结
Chromatin Regulatory Targets for Anticancer Therapeutics
26天前
已完结
The LSD1 Inhibitor Ory-1001 (ladademstat) in Combination with Menin Inhibitor SNDX-5613 (revumenib) Has Synergistic in Vitro Activity in KMT2A-Rearranged AML Models
26天前
已完结
KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
26天前
已完结
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
26天前
已完结
CRISPR–ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia
26天前
已完结
Ziftomenib (KO-539): a potent and selective Menin inhibitor for the treatment of recurrent or refractory acute myeloid leukemia
1个月前
已完结
皖公网安备34019202002308
